These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3064 related articles for article (PubMed ID: 17562522)
21. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454 [TBL] [Abstract][Full Text] [Related]
22. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
23. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
24. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935 [TBL] [Abstract][Full Text] [Related]
25. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Stavitsky K; Brickman AM; Scarmeas N; Torgan RL; Tang MX; Albert M; Brandt J; Blacker D; Stern Y Arch Neurol; 2006 Oct; 63(10):1450-6. PubMed ID: 17030662 [TBL] [Abstract][Full Text] [Related]
26. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220 [TBL] [Abstract][Full Text] [Related]
27. Mild cognitive impairment: a risk indicator of later dementia, or a preclinical phase of the disease? Guarch J; Marcos T; Salamero M; Gastó C; Blesa R Int J Geriatr Psychiatry; 2008 Mar; 23(3):257-65. PubMed ID: 17668419 [TBL] [Abstract][Full Text] [Related]
28. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia. Rountree SD; Waring SC; Chan WC; Lupo PJ; Darby EJ; Doody RS Dement Geriatr Cogn Disord; 2007; 24(6):476-82. PubMed ID: 17992015 [TBL] [Abstract][Full Text] [Related]
29. Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Lopez OL; Kuller LH; Becker JT; Dulberg C; Sweet RA; Gach HM; Dekosky ST Arch Neurol; 2007 Mar; 64(3):416-20. PubMed ID: 17353386 [TBL] [Abstract][Full Text] [Related]
31. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project. Mariani E; Monastero R; Ercolani S; Rinaldi P; Mangialasche F; Costanzi E; Vitale DF; Senin U; Mecocci P; Int J Geriatr Psychiatry; 2008 May; 23(5):523-30. PubMed ID: 18058828 [TBL] [Abstract][Full Text] [Related]
32. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease]. Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317 [TBL] [Abstract][Full Text] [Related]
33. Neuropathology of older persons without cognitive impairment from two community-based studies. Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647 [TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145 [TBL] [Abstract][Full Text] [Related]
36. VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years. Jungwirth S; Weissgram S; Zehetmayer S; Tragl KH; Fischer P Int J Geriatr Psychiatry; 2005 May; 20(5):452-8. PubMed ID: 15852463 [TBL] [Abstract][Full Text] [Related]
37. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria. Visser PJ; Verhey FR Psychol Med; 2008 Jan; 38(1):113-22. PubMed ID: 17451628 [TBL] [Abstract][Full Text] [Related]
38. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Palmer K; Bäckman L; Winblad B; Fratiglioni L Am J Geriatr Psychiatry; 2008 Jul; 16(7):603-11. PubMed ID: 18591580 [TBL] [Abstract][Full Text] [Related]
39. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup. Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009 [TBL] [Abstract][Full Text] [Related]